Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 9
2003 16
2004 10
2005 8
2006 4
2007 7
2008 11
2009 7
2010 9
2011 14
2012 14
2013 15
2014 15
2015 18
2016 20
2017 26
2018 12
2019 20
2020 28
2021 21
2022 19
2023 17
2024 17
2025 19
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

328 results

Results by year

Filters applied: . Clear all
Page 1
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells.
Brand A, Singer K, Koehl GE, Kolitzus M, Schoenhammer G, Thiel A, Matos C, Bruss C, Klobuch S, Peter K, Kastenberger M, Bogdan C, Schleicher U, Mackensen A, Ullrich E, Fichtner-Feigl S, Kesselring R, Mack M, Ritter U, Schmid M, Blank C, Dettmer K, Oefner PJ, Hoffmann P, Walenta S, Geissler EK, Pouyssegur J, Villunger A, Steven A, Seliger B, Schreml S, Haferkamp S, Kohl E, Karrer S, Berneburg M, Herr W, Mueller-Klieser W, Renner K, Kreutz M. Brand A, et al. Among authors: seliger b. Cell Metab. 2016 Nov 8;24(5):657-671. doi: 10.1016/j.cmet.2016.08.011. Epub 2016 Sep 15. Cell Metab. 2016. PMID: 27641098 Free article.
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages.
Petroni G, Galassi C, Gouin KH 3rd, Chen HH, Buqué A, Bloy N, Yamazaki T, Sato A, Beltrán-Visiedo M, Campia G, Jiménez-Cortegana C, Shah A, Kirchmair A, Massa C, Wickenhauser C, de Andrea CE, Navarro-Rubio B, Serrano-Mendioroz I, Navarro Manzano E, Satty AM, Rippon B, Finotello F, Trajanoski Z, Zhou XK, Scandura JM, García-Martínez E, Ayala de la Peña F, Rodríguez-Ruiz ME, Seliger B, Sánchez-Margalet V, de la Cruz-Merino L, Basho RK, Shiao SL, McArthur HL, Formenti SC, Knott SRV, Galluzzi L. Petroni G, et al. Among authors: seliger b. Nat Cancer. 2025 Oct;6(10):1656-1675. doi: 10.1038/s43018-025-01007-z. Epub 2025 Jul 7. Nat Cancer. 2025. PMID: 40624238
NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis.
Glasner A, Levi A, Enk J, Isaacson B, Viukov S, Orlanski S, Scope A, Neuman T, Enk CD, Hanna JH, Sexl V, Jonjic S, Seliger B, Zitvogel L, Mandelboim O. Glasner A, et al. Among authors: seliger b. Immunity. 2018 Jan 16;48(1):107-119.e4. doi: 10.1016/j.immuni.2017.12.007. Epub 2018 Jan 9. Immunity. 2018. PMID: 29329948 Free article.
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols.
Cottrell TR, Lotze MT, Ali A, Bifulco CB, Capitini CM, Chow LQM, Cillo AR, Collyar D, Cope L, Deutsch JS, Dubrovsky G, Gnjatic S, Goh D, Halabi S, Kohanbash G, Maecker HT, Maleki Vareki S, Mullin S, Seliger B, Taube J, Vos W, Yeong J, Anderson KG, Bruno TC, Chiuzan C, Diaz-Padilla I, Garrett-Mayer E, Glitza Oliva IC, Grandi P, Hill EG, Hobbs BP, Najjar YG, Pettit Nassi P, Simons VH, Subudhi SK, Sullivan RJ, Takimoto CH. Cottrell TR, et al. Among authors: seliger b. J Immunother Cancer. 2025 Mar 7;13(3):e010928. doi: 10.1136/jitc-2024-010928. J Immunother Cancer. 2025. PMID: 40054999 Free PMC article.
Basis of PD1/PD-L1 Therapies.
Seliger B. Seliger B. J Clin Med. 2019 Dec 8;8(12):2168. doi: 10.3390/jcm8122168. J Clin Med. 2019. PMID: 31817953 Free PMC article. Review.
Role of HLA-G in Viral Infections.
Jasinski-Bergner S, Schmiedel D, Mandelboim O, Seliger B. Jasinski-Bergner S, et al. Among authors: seliger b. Front Immunol. 2022 Feb 14;13:826074. doi: 10.3389/fimmu.2022.826074. eCollection 2022. Front Immunol. 2022. PMID: 35237271 Free PMC article. Review.
Immunotherapy of Breast Cancer.
Seliger B. Seliger B. Breast Care (Basel). 2018 Mar;13(1):5-6. doi: 10.1159/000486927. Epub 2018 Feb 13. Breast Care (Basel). 2018. PMID: 29950960 Free PMC article. No abstract available.
HIV status alters immune cell infiltration and activation profile in women with breast cancer.
Bauer M, Santos P, Wilfer A, van den Berg E, Zietsman A, Vetter M, Kaufhold S, Wickenhauser C, Dos-Santos-Silva I, Chen WC, Cubasch H, Murugan N, McCormack V, Joffe M, Seliger B, Kantelhardt E. Bauer M, et al. Among authors: seliger b. Nat Commun. 2025 May 20;16(1):4699. doi: 10.1038/s41467-025-59408-8. Nat Commun. 2025. PMID: 40393975 Free PMC article.
Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages.
Petroni G, Galassi C, Gouin KH 3rd, Chen HH, Buqué A, Bloy N, Yamazaki T, Sato A, Beltrán-Visiedo M, Campia G, Jiménez-Cortegana C, Shah A, Kirchmair A, Massa C, Wickenhauser C, de Andrea CE, Navarro-Rubio B, Serrano-Mendioroz I, Navarro Manzano E, Satty AM, Rippon B, Finotello F, Trajanoski Z, Zhou XK, Scandura JM, García-Martínez E, Ayala de la Peña F, Rodríguez-Ruiz ME, Seliger B, Sánchez-Margalet V, de la Cruz-Merino L, Basho RK, Shiao SL, McArthur HL, Formenti SC, Knott SRV, Galluzzi L. Petroni G, et al. Among authors: seliger b. Nat Cancer. 2025 Oct;6(10):1754. doi: 10.1038/s43018-025-01036-8. Nat Cancer. 2025. PMID: 40702362 No abstract available.
328 results